Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints

被引:0
|
作者
Kirchner, Marietta [1 ]
Schuepke, Stefanie [2 ,3 ,4 ]
Kieser, Meinhard [1 ,5 ]
机构
[1] Heidelberg Univ, Inst Med Biometry, Heidelberg, Germany
[2] Privatpraxis Kardiol, Frankfurt, Germany
[3] Deutsch Herzzentrum Munich, ISARes Ctr, Munich, Germany
[4] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Berlin, Germany
[5] Heidelberg Univ, Inst Med Biometry, Im Neuenheimer Feld 130 3, D-69120 Heidelberg, Germany
关键词
allocation ratio; clinical trial; power; sample size; UNEQUAL RANDOMIZATION; CLINICAL-TRIALS;
D O I
10.1002/pst.2375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The sample size of a clinical trial has to be large enough to ensure sufficient power for achieving the aim the study. On the other side, for ethical and economical reasons it should not be larger than necessary. The sample size allocation is one of the parameters that influences the required total sample size. For two-arm superiority and non-inferiority trials with binary endpoints, we performed extensive computations over a wide range of scenarios to determine the optimal allocation ratio that minimizes the total sample size if all other parameters are fixed. The results demonstrate, that for both superiority and non-inferiority trials the optimal allocation may deviate considerably from the case of equal sample size in both groups. However, the saving in sample size when allocating the total sample size optimally as compared to balanced allocation is typically small.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Methodological aspects of superiority, equivalence, and non-inferiority trials
    Stefanos, Roumeliotis
    Graziella, D. 'Arrigo
    Giovanni, Tripepi
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (06) : 1085 - 1091
  • [32] Methodological aspects of superiority, equivalence, and non-inferiority trials
    Roumeliotis Stefanos
    D.’Arrigo Graziella
    Tripepi Giovanni
    [J]. Internal and Emergency Medicine, 2020, 15 : 1085 - 1091
  • [33] Multiple assessments of non-inferiority trials with ordinal endpoints
    Xu, Wenfu
    Hou, Yuli
    Lu, Tong-Yu
    [J]. STATISTICS IN MEDICINE, 2023, 42 (08) : 1113 - 1126
  • [34] Bayesian sample-size determination methods considering both worthwhileness and unpromisingness for exploratory two-arm randomized clinical trials with binary endpoints
    Kakizume, Tomoyuki
    Zhang, Fanghong
    Kawasaki, Yohei
    Daimon, Takashi
    [J]. PHARMACEUTICAL STATISTICS, 2020, 19 (01) : 71 - 83
  • [35] Practical guide to sample size calculations: non-inferiority and equivalence trials
    Flight, Laura
    Julious, Steven A.
    [J]. PHARMACEUTICAL STATISTICS, 2016, 15 (01) : 80 - 89
  • [36] Minimizing sample size in non-inferiority safety trials with small probabilities
    de Boo, T
    Zielhuis, G
    Hendriks, J
    [J]. CONTROLLED CLINICAL TRIALS, 2003, 24 : 61S - 62S
  • [37] On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them
    Roehmel, Joachim
    Gerlinger, Christoph
    Benda, Norbert
    Laeuter, Juergen
    [J]. BIOMETRICAL JOURNAL, 2006, 48 (06) : 916 - 933
  • [38] Methodology of superiority vs. equivalence trials and non-inferiority trials
    Christensen, Erik
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 (05) : 947 - 954
  • [39] Allowing for stratification in sample size planning of two-arm trials with continuous or binary outcome: Overview and tutorial
    Wellek, Stefan
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2022, 31 (04) : 753 - 776
  • [40] OUTCOMES OF CONTEMPORARY NON-INFERIORITY VERSUS SUPERIORITY CARDIOVASCULAR TRIALS
    Dreyfus, Isaac
    Varunok, Nicholas
    Madhavan, Mahesh
    Burton, John
    Redfors, Bjorn
    Collier, Timothy
    Rossello, Xavier
    Owen, Ruth
    Francese, Dominic
    Desai, Nihar
    Ross, Joseph
    Kaul, Sanjay
    Pocock, Stuart
    Stone, Gregg
    Krumholz, Harlan
    Bikdeli, Behnood
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1640 - 1640